Lin Cong

ORCID: 0000-0002-1334-9047 · 3 papers in corpus
review 2026
Biomarker research ·doi:10.1186/s40364-026-00908-0

Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a paradigm-shifting therapeutic strategy in oncology, demonstrating significant synthetic lethality in tumors characterized by homologous recombination deficiency. Due to their …

rct 2021
·doi:10.18001/trs.7.5.1.105

Objective: To explore the clinical effect of moxifen tablets combined with medroxyprogesterone acetate injection on patients with endometriosis. Methods: 90 patients with endometriosis from August 2018 to March 2019 were randomly divided in…

case-report 2020
International journal of surgery case reports ·doi:10.1016/j.ijscr.2020.04.084

INTRODUCTION: We describe a patient with a large cystic adenomyosis of the uterus who was treated by a laparoscopic approach. CASE PRESENTATION: A 38-year-old woman presented with dysmenorrhoea for 4 months. A 104 mm × 55 mm × 60 mm cystic…